Predicting Early Disease Recurrence of Pancreatic Cancer following Surgery: Determining the Role of NUDT15 as a Prognostic Biomarker

SIMPLE SUMMARY: Overall survival rates for pancreatic cancer remain poor. Surgery serves as the only curative treatment strategy. A proportion of patients develop early disease recurrence despite undergoing adjuvant chemotherapy. The ability to identify this high-risk patient cohort may allow for a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Daniel Llwyd, Willenbrock, Frances, Soonawalla, Zahir, Mukherjee, Somnath, O’Neill, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032287/
https://www.ncbi.nlm.nih.gov/pubmed/35448180
http://dx.doi.org/10.3390/curroncol29040206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032287/
https://www.ncbi.nlm.nih.gov/pubmed/35448180
http://dx.doi.org/10.3390/curroncol29040206

Ejemplares similares